Rock Creek Group LLC Purchases 83,383 Shares of Sotera Health Company $SHC

Rock Creek Group LLC purchased a new stake in Sotera Health Company (NASDAQ:SHC – Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 83,383 shares of the company’s stock, valued at approximately $1,542,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. BlackRock Inc. acquired a new stake in Sotera Health in the second quarter worth approximately $428,635,000. Sculptor Capital LP acquired a new stake in shares of Sotera Health during the second quarter valued at approximately $426,000,000. Jupiter Topco LLC acquired a new stake in Sotera Health during the 2nd quarter valued at $149,137,000. Two Seas Capital LP purchased a new stake in Sotera Health in the 2nd quarter worth about $103,590,000. Finally, Lakewood Capital Management LP purchased a new stake in shares of Sotera Health in the second quarter worth approximately $70,638,000. 91.03% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on SHC shares. Weiss Ratings downgraded Sotera Health from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, October 23rd. JPMorgan Chase & Co. decreased their price target on shares of Sotera Health from $17.00 to $15.00 and set an “underweight” rating for the company in a report on Wednesday, November 4th. Wall Street Zen downgraded shares of Sotera Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, November 7th. Citigroup raised their price objective on Sotera Health from $23.00 to $25.00 and gave the stock a “buy” rating in a research report on Friday, August 7th. Finally, Piper Sandler reissued an “overweight” rating and issued a $25.00 price target on shares of Sotera Health in a research report on Tuesday, September 8th. Seven investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $21.14.

Read Our Latest Stock Analysis on SHC

Insider Activity at Sotera Health

In related news, Chairman Michael B. Jr. Petras sold 850,000 shares of the company’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $18.50, for a total value of $15,725,000.00. Following the completion of the sale, the chairman owned 3,969,393 shares in the company, valued at approximately $73,433,770.50. This represents a 17.64% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. 15.36% of the stock is currently owned by company insiders.

Sotera Health Price Performance

Shares of SHC traded up $0.31 during mid-day trading on Friday, hitting $16.61. 2,647,530 shares of the company traded hands, compared to its average volume of 2,660,564. The stock has a market capitalization of $4.74 billion, a price-to-earnings ratio of 27.68 and a beta of 1.94. Sotera Health Company has a one year low of $13.09 and a one year high of $19.85. The company has a current ratio of 3.13, a quick ratio of 2.91 and a debt-to-equity ratio of 3.04. The business has a 50-day moving average of $17.96 and a 200 day moving average of $16.91.

Sotera Health (NASDAQ:SHC – Get Free Report) last issued its quarterly earnings results on Tuesday, November 3rd. The company reported $0.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.27 by $0.02. Sotera Health had a return on equity of 38.46% and a net margin of 14.11%. The business had revenue of $324.89 million for the quarter, compared to analyst estimates of $319.86 million. During the same quarter in the prior year, the firm posted $0.26 earnings per share. The firm’s revenue for the quarter was up 4.4% compared to the same quarter last year. As a group, equities analysts expect that Sotera Health Company will post 0.89 earnings per share for the current fiscal year.

Sotera Health Company Profile

(Free Report)

Sotera Health Company is a global provider of sterilization, laboratory testing and advisory services for the medical device, pharmaceutical and food industries. Its services help customers assess product safety, meet regulatory requirements and prepare products for use. Through Sterigenics, the company provides contract sterilization using technologies including ethylene oxide, gamma irradiation and electron beam processing. Nelson Labs offers microbiological and analytical testing, as well as consulting, for medical devices and pharmaceutical products.

See Also

Want to see what other hedge funds are holding SHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sotera Health Company (NASDAQ:SHC – Free Report).

Institutional Ownership by Quarter for Sotera Health (NASDAQ:SHC)

Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.